Email Alert RSS
Turn off MathJax
Article Contents
Abstract
References
Related Articles
ZHANG Qian, WANG Haidong, YANG Huijun, JIN Fangmei, KAN Lili, BAI Songsong. Exploring the Mechanism and Intervention Strategies of Osteoporosis Based on the TLR4 Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0536
Citation: ZHANG Qian, WANG Haidong, YANG Huijun, JIN Fangmei, KAN Lili, BAI Songsong. Exploring the Mechanism and Intervention Strategies of Osteoporosis Based on the TLR4 Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0536
shu

Exploring the Mechanism and Intervention Strategies of Osteoporosis Based on the TLR4 Signaling Pathway

  • 1 Department 2 of Rheumatology and Orthopedics, Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China;

  • 2 Clinical College of Traditional Chinese Medicine, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, China

Funds: 

High level Key Discipline Construction Project of Traditional Chinese Medicine by the State Administration of Traditional Chinese Medicine (National Medical Education Letter 2023-85)

Lanzhou Youth Science and Technology Talent Innovation Project (2023-QN-12)

More Information
  • Received Date: July 13, 2024
  • Accepted Date: November 03, 2024
  • Available Online: December 02, 2024
    Graphical Abstract
    • Abstract
  • Osteoporosis is a common bone metabolism disease， with a complex pathogenesis that has not been fully elucidated yet. In recent years， studies have found that the Toll-like 4 receptor (TLR4) signaling pathway plays an important role in the occurrence and development of osteoporosis. TLR4 is an important immune receptor， mainly expressed in immune cells and involved in the body's inflammatory and immune responses. In osteoporosis， the TLR4 signaling pathway can affect bone metabolism and remodeling through various mechanisms. Therefore， exploring the role of the TLR4 signaling pathway in osteoporosis is of great significance for the prevention and treatment of osteoporosis. Research on the TLR4 signaling pathway provides new ideas and methods for the treatment of osteoporosis. Future research should further explore the mechanism of action of the TLR4 signaling pathway， develop more therapeutic drugs that regulate the TLR4 signaling pathway， and verify their efficacy in osteoporosis through clinical trials， providing more options for clinical treatment of osteoporosis.
    • FullText(HTML)
    • References (45)
  • [1]
    Qin Y， Yang X， Ning Z. Causal roles of educational duration in bone mineral density and risk f actors for osteoporosis： a Mendelian randomization study. BMC Musculoskelet Disord. 2024 May 2;25(1)： 345.
    [2]
    Chen FP， Lin YC， Lin YJ， et al. Relationship between Serum 25-hydroxyvitamin D and Bone Mineral Density， Fracture Risk， and Bone Metabolism in Adults with Osteoporosis/Fractures. End ocr Pract. 2024 Apr 29： S1530-891X(24)00503-2.
    [3]
    Emami Meybodi SM， Moradi Moraddahande F， Dehghani Firoozabadi A. Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line. Heliyon. 2024 Apr 22;10(9)： e29858.
    [4]
    Gitlin AD， Maltzman A， Kanno Y， et al. N4BP1 coordinates ubiquitin-dependent crosstalk within the IκB kinase family to limit Toll-like receptor signaling and inflammation. Immunity. 2024 Ap r 26： S1074-7613(24)00209-7.
    [5]
    Wang K， Wu J， Deng M， et al. Associations of healthy eating index-2015 with osteoporosis and low bone mass density in postmenopausal women： a population-based study from NHANES 2007-2018. Front Nutr. 2024 Apr 17;11： 1388647.
    [6]
    Guo C， Ruan J， Li Z， et al. Cadmium promoted LPS-induced inflammation through TLR4/IκBα/ NFκ-B signaling by increasing ROS-mediated incomplete autophagy. Ecotoxicol Environ Saf. 2024 May 1;278： 116405.
    [7]
    Chen P， Guo Z， Lei J， et al. Pomegranate polyphenol punicalin ameliorates lipopolysaccharide-in duced memory impairment， behavioral disorders， oxidative stress， and neuroinflammation via inhi bition of TLR4-NF-кB pathway. Phytother Res. 2024 May 2.
    [8]
    Kashiwakura JI， Matsuda T. [Understanding New Regulatory Mechanism of TCR Signal Transduct ion]. Yakugaku Zasshi. 2024;144(5)： 497-501.
    [9]
    Shaukat A， Rajput SA， Ali M， et al. Therapeutic administration of Luteolin protects against Esch erichia coli-derived Lipopolysaccharide-triggered Inflammatory Response and Oxidative Injury. Acta Trop. 2024 Apr 29： 107236.
    [10]
    Han L， Tang K， Fang XL， et al. Kuicolong-yu enema decoction retains traditional Chinese medi cine enema attenuates inflammatory response ulcerative colitis through TLR4/NF-κB signaling path way. World J Gastrointest Surg. 2024 Apr 27;16(4)： 1149-1154.
    [11]
    Huang Y， Jiang C， Liu X， et al. Melatonin suppresses TLR4-mediated RSV infection in the cent ral nervous cells by inhibiting NLRP3 inflammasome formation and autophagy. J Cell Mol Med. 2024 May;28(9)： e18338.
    [12]
    Ami D， Franco AR， Artusa V， et al. Vibrational spectroscopy coupled with machine learning she ds light on the cellular effects induced by rationally designed TLR4 agonists. Talanta. 2024 Apr 17;275： 126104.
    [13]
    Ohno R， Mainka M， Kirchhoff R， et al. Sterol Derivatives Specifically Increase Anti-Inflammator y Oxylipin Formation in M2-like Macrophages by LXR-Mediated Induction of 15-LOX. Molecules. 2024 Apr 12;29(8)： 1745.
    [14]
    Wu J， Huang H， Gong L， et al. A Flavonoid Glycoside Compound from Siraitia grosvenorii with Anti-Inflammatory and Hepatoprotective Effects In Vitro. Biomolecules. 2024 Apr 7;14(4)： 450.
    [15]
    Yokosawa T， Miyagawa S， Suzuki W， et al. The E3 Ubiquitin Protein Ligase LINCR Amplifies the TLR-Mediated Signals through Direct Degradation of MKP1. Cells. 2024 Apr 15;13(8)： 687.
    [16]
    Persaud AT， Khela J， Fernandes C， et al. Virion-incorporated CD14 enables HIV-1 to bind LPS and initiate TLR4 signaling in immune cells. J Virol. 2024 Apr 25： e0036324.
    [17]
    Wang N， Li C， Gao X， et al. Co-exposure to lead and high-fat diet aggravates systemic inflamm ation in mice by altering gut microbiota and the LPS/TLR4 Pathway. Metallomics. 2024 Apr 24： mfae022.
    [18]
    Zhang L， Xu F， Yang Y， et al. PM2.5 exposure upregulates pro-inflammatory protein expression i n human microglial cells via oxidant stress and TLR4/NF-κB pathway. Ecotoxicol Environ Saf. 2024 Apr 23;277： 116386.
    [19]
    Wan Z， Wang X， Fu Z， et al. Toll-like receptor activation regulates the paracrine effect of adip ose-derived mesenchymal stem cells on reversing osteoarthritic phenotype of chondrocytes. Mol Bi ol Rep. 2024 Apr 20;51(1)： 550.
    [20]
    Wu X， Li L， Jinhabure， et al. Radix Sophorae Flavescentis of Sophora flavescens Aiton inhibits LPS-induced macrophage pro-inflammatory response via regulating CFHR2 expression. J Ethnophar macol. 2024 Apr 17： 118210.
    [21]
    Zhu R， Zhang Y， He W， et al. Wogonoside alleviates microglia-mediated neuroinflammation via TLR4/MyD88/NF-κB signaling axis after spinal cord injury. Eur J Pharmacol. 2024 Apr 16;973： 176566.
    [22]
    He J， He Z， Wang H， et al. Caffeic acid alleviates skeletal muscle atrophy in 5/6 nephrectomy rats through the TLR4/MYD88/NF-kB pathway. Biomed Pharmacother. 2024 May;174： 116556.
    [23]
    Hildebrand D， Metz-Zumaran C， Jaschkowitz G， et al. Silencing SOCS1 via Liposome-Packed si RNA Sustains TLR4-Ligand Adjuvant. Front Immunol. 2019 Jun 4;10： 1279.
    [24]
    Samy AM， Kandeil MA， Sabry D， et al. Exosomal miR-122， miR-128， miR-200， miR-298， an d miR-342 as novel diagnostic biomarkers in NAFL/NASH： Impact of LPS/TLR-4/FoxO3 pathwa y. Arch Pharm (Weinheim). 2024 Apr;357(4)： e2300631.
    [25]
    Stefik D， Vranic V， Ivkovic N， et al. Potential Impact of Polymorphisms in Toll-like Receptors 2， 3， 4， 7， 9， miR-146a， miR-155， and miR-196a Genes on Osteoarthritis Susceptibility. Biolog y (Basel). 2023 Mar 16;12(3)： 458.
    [26]
    Zhang Y， He X， Wang K， et al. Irisin alleviates obesity-induced bone loss by inhibiting interleu kin 6 expression via TLR4/MyD88/NF-κB axis in adipocytes. J Adv Res. 2024 Apr 16： S2090-1232(24)00156-5.
    [27]
    Cui H， Li J， Li X， et al. TNF-α promotes osteocyte necroptosis by upregulating TLR4 in postme nopausal osteoporosis. Bone. 2024 May;182： 117050.
    [28]
    肖豪， 黄福锦， 黄夏荣， 等.脉冲电磁场抑制骨质疏松大鼠骨髓间充质干细胞自噬的机制研究[J].中国康复医学杂志， 2023， 38(10)： 1351-1357.
    [29]
    Shen X， Lan C， Lin Y， et al. Suppression of TLR4 prevents diabetic bone loss by regulating F TO-mediated m6A modification. Int Immunopharmacol. 2023 Sep;122： 110510.
    [30]
    Yu YF， Yao PQ， Wang ZK， et al. MiR-137 promotes TLR4/NF-κB pathway activity through tar geting KDM4A， inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells and aggravates osteoporosis. J Orthop Surg Res. 2023 Jun 21;18(1)： 444.
    [31]
    Chen H， Zheng Q， Lv Y， et al. CUL4A-mediated ZEB1/microRNA-340-5p/HMGB1 axis promote s the development of osteoporosis. J Biochem Mol Toxicol. 2023 Aug;37(8)： e23373.
    [32]
    李伟， 项芬芬， 陈思萍， 等.Asprosin在2 型糖尿病合并骨质疏松患者中的变化及其与TLR4/JNK/I L-1β通路的关系[J].中国骨质疏松杂志， 2024， 30(01)： 32-36.
    [33]
    Liang B， Shen X， Lan C， et al. Glycolipid toxicity induces osteogenic dysfunction via the TLR4/S100B pathway. Int Immunopharmacol. 2021 Aug;97： 107792.
    [34]
    Wang J， Chen J， Zhang B， et al. IL-6 regulates the bone metabolism and inflammatory microen vironment in aging mice by inhibiting Setd7. Acta Histochem. 2021 Jul;123(5)： 151718.
    [35]
    Xie H， Cao L， Ye L， et al. The miR-1906 mimic attenuates bone loss in osteoporosis by downregulating the TLR4/MyD88/NF-κB pathway. Physiol Int. 2021 Nov 6;107(4)： 469-478.
    [36]
    田峰， 涂来勇， 张恩丰， 等.鸢尾素抑制炎症因子表达促成骨分化改善糖尿病小鼠骨代谢的研究[J]. 中国骨质疏松杂志， 2024， 30(04)： 511-516.
    [37]
    Yan N， Wen DS， Zhao YR， et al. Epimedium sagittatum inhibits TLR4/MD-2 mediated NF-κB s ignaling pathway with anti-inflammatory activity. BMC Complement Altern Med. 2018 Nov 13;18(1)： 303.
    [38]
    Zhang D， Liang J， Qu S， et al. Metabolomics and pharmacodynamic analysis unveil the therapeu tic role of icaritin on osteoporosis rats. J Pharm Biomed Anal. 2024 Apr 15;241： 115979.
    [39]
    查涛， 高梅红， 王松华.利拉鲁肽对糖尿病骨质疏松症大鼠骨密度和胰岛素抵抗的影响[J].中国临床药理学杂志， 2023， 39(18)： 2659-2663.
    [40]
    邓惠成.吡那地尔激活TLR4改善大鼠骨质疏松的作用机制研究[D].右江民族医学院， 2023.
    [41]
    殷豪.米糠来源生物活性肽改善骨质疏松症的功效与机制研究[D].中南大学， 2023.
    [42]
    张洪然， 刘梦， 孙悦， 等.熊果酸对酒精性骨质疏松大鼠的骨保护作用[J].中华骨质疏松和骨矿盐疾病杂志， 2022， 15(04)： 344-352.
    [43]
    詹兴洪， 章国荣， 罗鸿波， 等.银杏叶提取物基于TLR4/NF-κB通路对骨质疏松大鼠的干预效果及作用机制[J].河北医药， 2024， 46(02)： 219-222.
    [44]
    张冬雪， 曲帅， 王明月， 等.淫羊藿总黄酮联合骨营养剂抗骨质疏松作用探讨[J].中国骨质疏松杂志， 2023， 29(12)： 1797-1804.
    [45]
    李博.鹿茸多肽通过TLR4信号通路抑制破骨细胞生成和骨吸收[D].吉林： 吉林大学， 2021.
    • Related Articles

  • Related Articles

    [1]LIU Yan, DONG Xingang, WANG Xiaoyuan, QI Gege, REN Yiqin, ZHOU Lianpeng, LI Hui, ZHANG Suqing, LI Weifeng. Research Progress on the Correlation Between Mitophagy and Vascular Cognitive Impairment[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0947
    [2]TIAN Kunling, CHEN Chuanning. Notch Signaling Pathway and Congenital Heart Disease[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(3): 649-654. DOI: 10.12290/xhyxzz.2023-0594
    [3]LIU Yandong, DENG Qiang, ZHANG Yanjun, LI Zhongfeng, PENG Randong, GUO Tiefeng, WANG Yurong, CHEN Bo. Research Progress on Emerging Signaling Pathways Related to Muscle Bone Symbiosis[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 147-152. DOI: 10.12290/xhyxzz.2023-0277
    [4]QI Xin, ZHANG Xiaogang, YU Haiyang, CHEN Xin, AN Wenbo, WANG Zhipeng, WANG Duoxian, LUO Pengfei, CHEN Yixin, MA Jiaojiao, QI Wei, HU Ziyang, LIU Jianjun. Research Progress on the Role of HMGB1 in Regulating the Function of Osteoarthritis Chondrocytes[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 141-146. DOI: 10.12290/xhyxzz.2023-0269
    [5]LIAN Hongqiang, ZHANG Lirong, XU Jiancheng, XU Tao, LI Chao, LI Xitao, JI Jing. Pathogenesis of Sarcopenia-Osteoporosis[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0953
    [6]WEI Jiaojiao, LIU Shiwei, DUAN Ruixue, LI Nan, WANG Jiangna. Effects of Vaspin on Pancreatic Beta Cell Function in Type 2 Diabetic Rats by AMPK/mTOR Autophagy Signaling Pathway[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(3): 543-552. DOI: 10.12290/xhyxzz.2022-0183
    [7]Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
    [8]ZHAO Xin, WEI Qing-xia, YANG Jun. The Regulation of Bone Morphogenetic Protein Signaling in Endothelial Physiology and Pulmonary Hypertension[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 720-726. DOI: 10.3969/j.issn.1674-9081.2020.06.015
    [9]Ya-ping LUO, Fang LI, Miao YU, Xiao-ping XING, Tai-ping ZHANG, Yu-pei ZHAO. Procedure Guideline of Glucagon-like Peptide-1 Receptor Positron Emission Tomography/Computed Tomography in Localizing Insulinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(4): 486-491. DOI: 10.3969/j.issn.1674-9081.2020.04.022
    [10]Zhao-jing XUE, Le SHEN, Zhi-yao WANG, Yu-guang HUANG. Feasibility of Signal Transducers and Activators of Transcription 3 Inhibitor WP1066 as a Novel Target for Neuropathic Pain[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(2): 142-147. DOI: 10.3969/j.issn.1674-9081.2014.02.003

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (79) PDF downloads (6) Cited by()
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close